Shares in Danish pharma group Novo Nordisk soared to a record high on Tuesday after a late-stage trial suggested its obesity drug
Shares in Danish pharma group Novo Nordisk soared to a record high on Tuesday after a late-stage trial suggested its obesity drug Wegovy could reduce the risk of heart attacks or stroke by 20 percent. Preliminary results showed that patients taking Wegovy had a 20 percent lower risk of suffering from a heart attack or […]
The post Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk appeared first on Insider Paper.
https://insiderpaper.com/weight-loss-drug-cuts-risk-of-heart-attack-strokes-novo-nordisk/
Comments
0 comment